Heart News and Research

RSS

Air pollution accounts for premature deaths from cardiovascular disease

In a current opinion article "Reduction of environmental pollutants for prevention of cardiovascular disease: it's time to act", published in the European Heart Journal this week.

9 Nov 2020

Pre-existing antibodies created during COVID-19 may protect children against new pandemic strain

Researchers at the Francis Crick Institute and University College London have found that some antibodies, created by the immune system during infection with common cold coronaviruses, can also target SARS-CoV-2 and may confer a degree of protection against the new viral strain.

9 Nov 2020

Study shows SARS-CoV-2 direct heart muscle cell infection, cell death, loss of contractility

In the study, published on the pre-print journal bioRxiv, the researchers revealed that SARS-CoV-2-infected EHTs manifested the typical characteristics of myocarditis or heart inflammation. These include the stimulation of immune cells, heart cell death, and decreased contractile force generation.

8 Nov 2020

FDA authorizes marketing of new device intended to provide temporary relief from sleep disturbances

Today, the U.S. Food and Drug Administration permitted marketing of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults 22 years or older who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder (PTSD).

8 Nov 2020

Children with Kawasaki Disease at increased risk for cardiovascular events 10 years later

New research shows that children with Kawasaki Disease remain at an increased risk for cardiovascular events more than 10 years after hospitalization for their condition, highlighting the need for long-term heart disease surveillance and risk reduction strategies for these young patients.

6 Nov 2020

Black patients with lupus have higher risk of stroke and ischemic heart disease

New research reveals that, in the U.S., Black patients with lupus have a threefold higher risk of stroke and a 24-fold higher risk of ischemic heart disease.

6 Nov 2020

Virginia Tech student receives NSERC award to develop minimally invasive treatment for glioblastoma

The Natural Sciences and Engineering Research Council of Canada (NSERC) supports research that results in "breakthrough answers to timeless questions." When choosing awardees, the council looks for creativity and innovation, two qualities they see at the heart of all research advances.

6 Nov 2020

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

New research shows that adults with systemic lupus erythematosus, who receive trimethoprim-sulfamethoxazole (TMP-SMX), a prophylactic therapy to help prevent pneumocystis pneumonia, are at high risk for adverse reactions to the drug, particularly if they are also positive for anti-Smith (anti-Sm) antibodies.

6 Nov 2020

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19

A new study shows that patients with rheumatic diseases across Africa, Southeast Asia, the Americas and Europe had trouble filling their prescriptions of antimalarial drugs, including hydroxychloroquine, during the 2020 global coronavirus pandemic, when antimalarials were touted as a possible COVID-19 treatment.

6 Nov 2020

Hydroxychloroquine not associated with prolonged heart rhythm intervals in RA or lupus patients

New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, discovers that use of hydroxychloroquine, a generic drug, does not cause any significant differences in QTc length or prolonged QTc, key measures of heart rate, in people with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE).

6 Nov 2020

Corticosteroid injections for knee OA do not speed up the progression of disease

New research shows that corticosteroid injections for knee OA treatment do not hasten a patient's progression to a total knee replacement when compared with hyaluronic acid injections.

6 Nov 2020

Women with interstitial lung disease may not need to terminate their pregnancies

A new study shows that women with interstitial lung disease (ILD) related to autoimmune disease may not need to terminate their pregnancies--despite the increased risk of adverse outcomes--provided they have close monitoring from their team of multidisciplinary physicians before, during and after pregnancy.

6 Nov 2020

How do low levels of oxygen damage the brain?

In this interview, Professor Paul Tesar and Kevin Allan speak to News-Medical about how low levels of oxygen damage the brain.

6 Nov 2020

Rapid rise in CRP levels predicts COVID-19 outcomes

Predicting the course of a COVID-19 patient's disease after hospital admission is essential to improving treatment.

6 Nov 2020

Deciphering heart-brain talk may help unlock the key to cardiovascular disease

The crosstalk of the heart and brain is continuous and deciphering those messages may help researchers unlock the key to cardiovascular disease, says Deeptankar DeMazumder, MD, PhD, assistant professor in the University of Cincinnati College of Medicine.

6 Nov 2020

Fear circuit extends far beyond the amygdala, research shows

When a frightful creature startles you, your brain may activate its fear-processing circuitry, sending your heart racing to help you escape the threat.

5 Nov 2020

Foods that cause inflammation tied to a higher risk of cardiovascular disease

A new study by researchers at the Harvard T.H. Chan School of Public Health has found that diets high in red and processed meat, sugary beverages, and refined grains promote inflammation in the body and increase the subsequent risk of heart disease and stroke.

5 Nov 2020

Heart News and Research

Air pollution accounts for premature deaths from cardiovascular disease

Pre-existing antibodies created during COVID-19 may protect children against new pandemic strain

Study shows SARS-CoV-2 direct heart muscle cell infection, cell death, loss of contractility

FDA authorizes marketing of new device intended to provide temporary relief from sleep disturbances

Children with Kawasaki Disease at increased risk for cardiovascular events 10 years later

Black patients with lupus have higher risk of stroke and ischemic heart disease

Virginia Tech student receives NSERC award to develop minimally invasive treatment for glioblastoma

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19

Hydroxychloroquine not associated with prolonged heart rhythm intervals in RA or lupus patients

Corticosteroid injections for knee OA do not speed up the progression of disease

Women with interstitial lung disease may not need to terminate their pregnancies

How do low levels of oxygen damage the brain?

Rapid rise in CRP levels predicts COVID-19 outcomes

Deciphering heart-brain talk may help unlock the key to cardiovascular disease

Fear circuit extends far beyond the amygdala, research shows

Foods that cause inflammation tied to a higher risk of cardiovascular disease

Persistent and extensive lung damage seen in COVID-19 patients

Study investigates the ebb and flow of brain ventricles

NIH awards grant totaling $19.5M for Down syndrome research project

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News